These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9020479)

  • 1. Midkine induces the transformation of NIH3T3 cells.
    Kadomatsu K; Hagihara M; Akhter S; Fan QW; Muramatsu H; Muramatsu T
    Br J Cancer; 1997; 75(3):354-9. PubMed ID: 9020479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increases their sensitivity to antiangiogenic therapy.
    Muramaki M; Miyake H; Hara I; Kamidono S
    Clin Cancer Res; 2003 Nov; 9(14):5152-60. PubMed ID: 14613994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.
    Stoica GE; Kuo A; Powers C; Bowden ET; Sale EB; Riegel AT; Wellstein A
    J Biol Chem; 2002 Sep; 277(39):35990-8. PubMed ID: 12122009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Truncated midkine induces transformation of cultured cells and short latency of tumorigenesis in nude mice.
    Nobata S; Shinozawa T; Sakanishi A
    Cancer Lett; 2005 Feb; 219(1):83-9. PubMed ID: 15694667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.
    Kurokawa M; Tanaka T; Tanaka K; Ogawa S; Mitani K; Yazaki Y; Hirai H
    Oncogene; 1996 Feb; 12(4):883-92. PubMed ID: 8632911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation.
    Iwashita T; Asai N; Murakami H; Matsuyama M; Takahashi M
    Oncogene; 1996 Feb; 12(3):481-7. PubMed ID: 8637703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midkine (MK), a heparin-binding growth/differentiation factor, is regulated by retinoic acid and epithelial-mesenchymal interactions in the developing mouse tooth, and affects cell proliferation and morphogenesis.
    Mitsiadis TA; Muramatsu T; Muramatsu H; Thesleff I
    J Cell Biol; 1995 Apr; 129(1):267-81. PubMed ID: 7698992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEN2A-RET-induced cellular transformation by activation of STAT3.
    Schuringa JJ; Wojtachnio K; Hagens W; Vellenga E; Buys CH; Hofstra R; Kruijer W
    Oncogene; 2001 Aug; 20(38):5350-8. PubMed ID: 11536047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells.
    Takei Y; Kadomatsu K; Matsuo S; Itoh H; Nakazawa K; Kubota S; Muramatsu T
    Cancer Res; 2001 Dec; 61(23):8486-91. PubMed ID: 11731432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of farnesyltransferase overexpression on cell growth and transformation.
    Nagase T; Kawata S; Nakajima H; Tamura S; Yamasaki E; Fukui K; Yamamoto K; Miyagawa J; Matsumura I; Matsuda Y; Matsuzawa Y
    Int J Cancer; 1999 Jan; 80(1):126-33. PubMed ID: 9935242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming activity of the RL-akt gene, a c-akt gene activated by long terminal repeat insertion in murine leukemia RL(male symbol)1 cells.
    Tanino M; Matsuo M; Uenaka A; Tsukuda K; Ouchida M; Nakayama E; Shimizu K
    Mol Carcinog; 1999 Dec; 26(4):286-97. PubMed ID: 10569805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key role of Shc signaling in the transforming pathway triggered by Ret/ptc2 oncoprotein.
    Mercalli E; Ghizzoni S; Arighi E; Alberti L; Sangregorio R; Radice MT; Gishizky ML; Pierotti MA; Borrello MG
    Oncogene; 2001 Jun; 20(27):3475-85. PubMed ID: 11429694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma.
    Cuccuru G; Lanzi C; Cassinelli G; Pratesi G; Tortoreto M; Petrangolini G; Seregni E; Martinetti A; Laccabue D; Zanchi C; Zunino F
    J Natl Cancer Inst; 2004 Jul; 96(13):1006-14. PubMed ID: 15240784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A; Thraves PJ; Dritschilo A; Notario V
    Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multiple endocrine neoplasia 2B RET in neuroblastoma cells alters cell adhesion in vitro, enhances metastatic behavior in vivo, and activates Jun kinase.
    Marshall GM; Peaston AE; Hocker JE; Smith SA; Hansford LM; Tobias V; Norris MD; Haber M; Smith DP; Lorenzo MJ; Ponder BA; Hancock JF
    Cancer Res; 1997 Dec; 57(23):5399-405. PubMed ID: 9393766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of biological phenotypes according to midkine expression in gastric cancer cells and their autocrine activities could be modulated by pentosan polysulfate.
    Rha SY; Noh SH; Kwak HJ; Wellstein A; Kim JH; Roh JK; Min JS; Kim BS; Chung HC
    Cancer Lett; 1997 Sep; 118(1):37-46. PubMed ID: 9310258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes.
    Carlomagno F; Vitagliano D; Guida T; Napolitano M; Vecchio G; Fusco A; Gazit A; Levitzki A; Santoro M
    Cancer Res; 2002 Feb; 62(4):1077-82. PubMed ID: 11861385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monomeric midkine induces tumor cell proliferation in the absence of cell-surface proteoglycan binding.
    Qiu L; Escalante CR; Aggarwal AK; Wilson PD; Burrow CR
    Biochemistry; 2000 May; 39(20):5977-87. PubMed ID: 10821669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of ret oncogenic activation in MEN2 inherited cancer syndromes.
    Xing S; Smanik PA; Oglesbee MJ; Trosko JE; Mazzaferri EL; Jhiang SM
    Endocrinology; 1996 May; 137(5):1512-9. PubMed ID: 8612479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
    Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.